LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

Search

Odonate Therapeutics Inc

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Odonate Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

22 dec. 2025, 23:54 UTC

Principalele dinamici ale pieței

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

22 dec. 2025, 19:08 UTC

Achiziții, Fuziuni, Preluări

Correction to Alphabet to Buy Intersect Article

22 dec. 2025, 17:21 UTC

Achiziții, Fuziuni, Preluări

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

22 dec. 2025, 16:46 UTC

Achiziții, Fuziuni, Preluări

Alphabet to Buy Intersect for $4.75 Billion in Cash

22 dec. 2025, 23:50 UTC

Market Talk

Nikkei May Decline as Yen Rebounds -- Market Talk

22 dec. 2025, 23:42 UTC

Market Talk

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

22 dec. 2025, 22:31 UTC

Câștiguri

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

22 dec. 2025, 22:31 UTC

Câștiguri

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

22 dec. 2025, 22:30 UTC

Câștiguri

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

22 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 dec. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

22 dec. 2025, 21:37 UTC

Achiziții, Fuziuni, Preluări

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

22 dec. 2025, 21:36 UTC

Achiziții, Fuziuni, Preluări

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

22 dec. 2025, 21:35 UTC

Achiziții, Fuziuni, Preluări

Capricorn to Acquire Prospective Package From Tempest Minerals

22 dec. 2025, 21:35 UTC

Achiziții, Fuziuni, Preluări

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

22 dec. 2025, 20:54 UTC

Achiziții, Fuziuni, Preluări

Middle West Partners Buys Paul Stuart From Mitsui & Co.

22 dec. 2025, 20:52 UTC

Achiziții, Fuziuni, Preluări

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

22 dec. 2025, 20:09 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

22 dec. 2025, 19:56 UTC

Market Talk

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

22 dec. 2025, 19:49 UTC

Achiziții, Fuziuni, Preluări

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

22 dec. 2025, 19:23 UTC

Market Talk

Mexico's Inflation Seen Easing in Early December -- Market Talk

22 dec. 2025, 19:23 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 dec. 2025, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

22 dec. 2025, 19:02 UTC

Market Talk

Precious Metals Climb to New Heights -- Market Talk

22 dec. 2025, 18:45 UTC

Market Talk

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

22 dec. 2025, 18:30 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

22 dec. 2025, 18:23 UTC

Achiziții, Fuziuni, Preluări

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

22 dec. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

22 dec. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

22 dec. 2025, 17:06 UTC

Achiziții, Fuziuni, Preluări

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Comparație

Modificare preț

Odonate Therapeutics Inc Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat